NCT03142334 2026-03-10KEYNOTE-564Merck Sharp & Dohme LLCPhase 3 Completed994 enrolled 10 charts 1 FDA
NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 1 FDA